Lifecore Biomedical Class Action Lawsuit: 6 Frequently Asked Questions

7/30/2024

INTRODUCTION TO THE LIFECORE BIOMEDICALCLASS ACTION LAWSUIT

Stock market data information. Pads with color diagrams and color shining on background. Tablet computer with business chart. Stock market graphs and charts analysis

Call Lifecore Biomedical stock loss lawyer Timothy L. Miles today about the Lifecore Biomedical class action lawsuit

The Lifecore Biomedical class action lawsuit seeks to represent purchasers or acquirers of Lifecore Biomedical, Inc. (NASDAQ: LFCR) securities between October 7, 2020 and March 19, 2024, inclusive (the “Class Period”). Captioned Carew v. Lifecore Biomedical, Inc., No. 24-cv-03028 (D. Minn.), the Lifecore Biomedical class action lawsuit charges Lifecore Biomedical and certain of Lifecore Biomedical’s top current and former executives with violations of the Securities Exchange Act of 1934.

If you have suffered losses in Lifecore Biomedical stock and are interested in becoming the lead plaintiff in the Lifecore Biomedical class action lawsuit or have any inquiries regarding your rights as a shareholder, please reach out to Lifecore Biomedical Stock Loss Lawyer Timothy L. Miles at no cost. You can contact him by calling 855/846-6529, sending an e-mail to [email protected], or filling out a contact form. Lead plaintiff motions for the Lifecore Biomedical class action lawsuit must be filed with the court no later than September 27, 2024.

Read on for answers to six of the most frequently asked questions from investors about the Lifecore Biomedical class action lawsuit.

what are the ALLEGATIONS IN THE LIFECORE BIOMEDICAL CLASS ACTION CLASS ACTION LAWSUIT?

Stock market chart,Stock market data on LED display concept , Selective Focus

Contact Timothy L Miles today for a free case evaluation in the Lifecore Biomedical class action lawsuit

Lifecore Biomedical purportedly designs, develops, manufactures, and sells differentiated products for biomaterials markets, and license technology applications to partners. The Lifecore Biomedical class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that:

Lifecore Biomedical maintained deficient internal controls over financial reporting;
As a result, Lifecore Biomedical issued several financial statements that were inaccurate and would need to be restated;
Lifecore Biomedical’s purported remediation efforts with respect to the foregoing deficiencies were ineffective;
the above impaired Lifecore Biomedical’s ability to timely file periodic reports with the U.S. Securities and Exchange Commission in compliance with NASDAQ listing requirements; and

Accordingly, Lifecore Biomedical’s financial position and/or prospects were materially overstated.

what is the THE LEAD PLAINTIFF DEADLINE IN THE CLASS ACTION AGAINST LIFECORE BIOMEDICAL?

Lead plaintiff motions for the Lifecore Biomedical class action lawsuit must be filed with the court no later than September 27, 2024. When a securities class action is filed such as the Lifecore Biomedical class action lawsuit:

The person who files the first complaint is required to publish a notice announcing the filing.
Anyone who wants to be lead plaintiff on behalf of the class must thereafter file a motion to be appointed as lead plaintiff(s) no later than 60 days after the notice was published.

what is THE LEAD PLAINTIFF PROCESS IN THE LIFECORE BIOMEDICAL CLASS ACTION LAWSUIT?

Under the Privative Securities Litigation Reform Act of 1995 (PSLRA):

Any investor who purchased and suffered losses in Lifecore Biomedical stock may seek appointment as lead plaintiff in the Lifecore Biomedical class action lawsuit.
A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class.
A lead plaintiff acts on behalf of all other class members in directing the class action lawsuit.
The lead plaintiff can select a law firm of its choice to litigate the securities class action lawsuit.
An investor’s ability to share in any potential future recovery of the class action lawsuit is not dependent upon serving as lead plaintiff.

what are THE BENEFITS OF SERVING AS A LEAD PLAINTIFF IN THE LIFECORE BIOMEDICAL CLASS ACTION LAWSUIT?

Negotiating more competitive attorney fees and reducing litigation costs.
Managing the litigation by overseeing the progress of the case and reviewing important filings.
Participating in mediation and settlement discussions.
Having a voice in decision-making processes regarding the settlement.
No financial risk, as lead counsel covers all costs and expenses and are paid only if they secure a settlement or judgment recovery for the class
Potentially enjoying long-term benefits from governance reform resulting from the litigation.

what are THE RESPONSIBILITIES THE LEAD PLAINTIFF WILL HAVE IN THE LIFECORE BIOMEDICAL CLASS ACTION LAWSUIT?

Selecting, monitoring, and overseeing Lead Counsel.
Reviewing and commenting on court filings on behalf of the class.
Discussing litigation strategies with the Lead Counsel.
Attending depositions (if necessary) and giving a deposition.
Attending hearings (if necessary).
Participating in mediation and the trial (if necessary).
Provide input on any decision concerning the settlement of the securities class action.

what is the ELIGIBILITY CRITERIA FOR LEAD PLAINTIFF APPOINTMENT IN THE LIFECORE BIOMEDICAL CLASS ACTION LAWSUIT?

Gold trade chart stock analysis on growth financial business money market 3d background with profit investment exchange graph data concept and global economy currency diagram price marketing research.

If you suffered losses in Lifecore Biomedical stock, call Timothy L. Miles today for a free case evaluation

To be eligible for appointment as the lead plaintiff in the Lifecore Biomedical class action lawsuit, an investor must meet the following criteria:

Purchased or acquired Lifecore Biomedical securities during the class period (October 7, 2020 to March 19, 2024)
Suffered financial losses as a result of the alleged securities fraud
Satisfies the typicality and adequacy requirements under the PSLRA

It is important to note that both U.S. and non-U.S. investors who meet these criteria may seek appointment as the lead plaintiff, as courts have consistently recognized the rights of non-U.S. investors in securities class actions. If you have further questions about your eligibility, do not hesitate to contact Timothy L. Miles at no charge anytime. (855) 846–6529 or [email protected].

CONTACT LIFECORE BIOMEDICAL STOCK LOSS LAWYER TODAY TIMOTHY L MILES TODAY ABOUT A LIFECORE BIOMEDICAL CLASS ACTION LAWSUIT

If you suffered losses in Lifecore Biomedical stock, contact Lifecore Biomedical stock loss lawyer Timothy L. Miles today for a free case evaluation about a Lifecore Biomedical class action lawsuit. Call today and see what a Lifecore Biomedical stock loss lawyer could do for you if you suffered losses in Lifecore Biomedical stock. This will most likely be the only call you need to make. (855) 846–6529 or [email protected].

The Law Offices of Timothy L. Miles
Tapestry at Brentwood Town Center
300 Centerview Dr., #247
Brentwood, TN 37027
Phone: (855) 846–6529
Email: [email protected]